RecruitingPriority 4 · Lower priorityNCT02863692
Registry of the German CLL Study Group
Plain-language summary
This is a research study collecting clinical information and/or biological samples from patients with T-cell prolymphocytic leukemia (T-PLL) who have been newly diagnosed and have not yet received treatment as well as those whose disease has come back or stopped responding to prior treatment to advance understanding of these diseases and improve future treatments. No experimental treatment is given as part of this study. This trial does not currently have sites in the United States.
Who can join (key eligibility)
- Age 18 Years or older
- Newly diagnosed, not yet treated
Final eligibility is determined by the trial team. This list is a starting point only.
What's being tested
- Treatment length
- Ask the trial team for details
- Visit frequency
- Ask the trial team for details